Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,006 | -7,242 | -10,565 | -4,140 | -2,730 |
| Depreciation Amortization | 26 | 30 | 33 | 16 | 5 |
| Accounts payable and accrued liabilities | -144 | -83 | 113 | -228 | 380 |
| Other Working Capital | -227 | -1,073 | 1,554 | -858 | 325 |
| Other Operating Activity | 594 | 685 | 605 | 785 | 841 |
| Operating Cash Flow | $-3,757 | $-7,683 | $-8,260 | $-4,425 | $-1,179 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -2 | -1 | -66 | -21 |
| Investing Cash Flow | $-3 | $-2 | $-1 | $-66 | $-21 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,456 | 3,698 | 4,088 | N/A | 17,638 |
| Other Financing Activity | 0 | 0 | -3 | 0 | 3,225 |
| Financing Cash Flow | $1,456 | $3,698 | $4,085 | $N/A | $20,863 |
| Beginning Cash Position | 7,779 | 11,767 | 15,944 | 20,435 | 771 |
| End Cash Position | 5,475 | 7,779 | 11,767 | 15,944 | 20,435 |
| Net Cash Flow | $-2,304 | $-3,987 | $-4,177 | $-4,491 | $19,664 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,757 | -7,683 | -8,260 | -4,425 | -1,179 |
| Capital Expenditure | -3 | -2 | -1 | -66 | -21 |
| Free Cash Flow | -3,760 | -7,686 | -8,262 | -4,491 | -1,200 |